# Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy

> **NCT05285332** · NA · NOT_YET_RECRUITING · sponsor: **Changhai Hospital** · enrollment: 362 (estimated)

## Conditions studied

- Breast Neoplasms
- Treatment
- Metastatic Breast Cancer
- Survival

## Interventions

- **PROCEDURE:** surgical treatment 1
- **PROCEDURE:** surgical treatment 2
- **DRUG:** Systemic therapy

## Key facts

- **NCT ID:** NCT05285332
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-08-01
- **Primary completion:** 2030-12-31
- **Final completion:** 2031-05-01
- **Target enrollment:** 362 (ESTIMATED)
- **Last updated:** 2022-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05285332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05285332, "Classified Treatment Strategy for De-novo Metastatic Breast Cancer After Systemic Adjuvant Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05285332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*